New Zealand markets closed

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1726+0.0011 (+0.64%)
At close: 04:00PM EST
0.1756 +0.00 (+1.74%)
After hours: 07:49PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 21.89M
Enterprise value -18.82M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.52
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.58

Trading information

Stock price history

Beta (5Y monthly) 2.14
52-week change 3-58.75%
S&P500 52-week change 3-9.08%
52-week high 30.6240
52-week low 30.1000
50-day moving average 30.1325
200-day moving average 30.2064

Share statistics

Avg vol (3-month) 34.19M
Avg vol (10-day) 31.74M
Shares outstanding 5125.28M
Implied shares outstanding 6N/A
Float 8124.68M
% held by insiders 10.48%
% held by institutions 118.01%
Shares short (12 Jan 2023) 43.13M
Short ratio (12 Jan 2023) 42.07
Short % of float (12 Jan 2023) 42.51%
Short % of shares outstanding (12 Jan 2023) 42.50%
Shares short (prior month 14 Dec 2022) 44.64M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-22.00%
Return on equity (ttm)-69.80%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-35.56M
EBITDA -33.25M
Net income avi to common (ttm)-41.73M
Diluted EPS (ttm)-0.3120
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)66.23M
Total cash per share (mrq)0.53
Total debt (mrq)25.52M
Total debt/equity (mrq)60.84
Current ratio (mrq)3.86
Book value per share (mrq)0.34

Cash flow statement

Operating cash flow (ttm)-39.79M
Levered free cash flow (ttm)-20.55M